Page 2 of 3.
Curetis to Present at Key Investor and Scientific Conferences in the Fourth Quarter 2017
MGI and Curetis to Collaborate on NGS-based Infectious Disease Diagnostics
Curetis Announces Financial Results for the First Six Months of 2017
Curetis Announces Management Board Changes
Curetis Partners with Biotest to support academic PEPPER Pentaglobin® Peritonitis Trial with Unyvero IAI Application
Curetis and MGI Advance Strategic Partnership in NGS-Based Molecular Microbiology
Curetis Expects Near-Term FDA Decision on De Novo Request